217 related articles for article (PubMed ID: 3919749)
1. Lack of inhibition of purine nucleoside phosphorylase and adenosine deaminase in patients treated with azathioprine.
Maddocks JL; Al-Safi SA
Br J Clin Pharmacol; 1985 Jan; 19(1):108-11. PubMed ID: 3919749
[TBL] [Abstract][Full Text] [Related]
2. Immune deficiency due to adenosine deaminase and purine nucleoside phosphorylase deficiency: a simple diagnostic test.
Maddocks JL; Al-Safi SA; Wilson G
J Clin Pathol; 1984 Nov; 37(11):1305-7. PubMed ID: 6438186
[TBL] [Abstract][Full Text] [Related]
3. Potential use of purine nucleosides and enzyme inhibitors for selective depletion of Thy-lymphoblasts from human bone marrow.
Russell NH; Hoffbrand AV; Bellingham AJ
Leuk Res; 1986; 10(3):325-9. PubMed ID: 3081767
[TBL] [Abstract][Full Text] [Related]
4. Effect of immunosuppressive agents on human T and B lymphoblasts.
Kazmers IS; Daddona PE; Dalke AP; Kelley WN
Biochem Pharmacol; 1983 Mar; 32(5):805-10. PubMed ID: 6404281
[TBL] [Abstract][Full Text] [Related]
5. Enzymes of purine metabolism in lymphoid neoplasms, clinical relevance for treatment with enzyme inhibitors.
Ho AD; Ganeshaguru K
Klin Wochenschr; 1988 Jun; 66(11):467-74. PubMed ID: 2841534
[TBL] [Abstract][Full Text] [Related]
6. Deoxyribonucleoside toxicity in adenosine deaminase and purine nucleoside phosphorylase deficiency: implications for the development of new immunosuppressive agents.
Carson DA; Kaye J
Ciba Found Symp; 1978; (68):115-33. PubMed ID: 115660
[TBL] [Abstract][Full Text] [Related]
7. Possible metabolic basis for the different immunodeficient states associated with genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase.
Carson DA; Wasson DB; Lakow E; Kamatani N
Proc Natl Acad Sci U S A; 1982 Jun; 79(12):3848-52. PubMed ID: 6808516
[TBL] [Abstract][Full Text] [Related]
8. Lymphospecific toxicity in adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency: possible role of nucleoside kinase(s).
Carson DA; Kaye J; Seegmiller JE
Proc Natl Acad Sci U S A; 1977 Dec; 74(12):5677-81. PubMed ID: 202960
[TBL] [Abstract][Full Text] [Related]
9. ADA and PNP deficiencies: how it all began.
Giblett ER
Ann N Y Acad Sci; 1985; 451():1-8. PubMed ID: 3935025
[No Abstract] [Full Text] [Related]
10. Differences in the activity of adenosine deaminase and of purine nucleoside phosphorylase and in the sensitivity to deoxypurine nucleosides between subpopulations of mouse thymocytes.
Sidi Y; Umiel T; Trainin N; Pinkhas J; Sperling O
Thymus; 1982 May; 4(3):147-54. PubMed ID: 6810516
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of adenosine deaminase and purine nucleoside phosphorylase and T-cell function in germfree mice and human peripheral blood.
Wiedl SC; Bealmear PM; Epstein J
Prog Clin Biol Res; 1985; 181():461-6. PubMed ID: 3927311
[No Abstract] [Full Text] [Related]
12. Inherited enzyme deficiencies and immunodeficiency: adenosine deaminase (ADA) and purine nucleoside phosphorylase (PNP) deficiencies.
Hirschhorn R
Clin Immunol Immunopathol; 1986 Jul; 40(1):157-65. PubMed ID: 3087666
[No Abstract] [Full Text] [Related]
13. Characterization of a cell culture model for the study of adenosine deaminase- and purine nucleoside phosphorylase-deficient immunologic disease.
Ullman B; Cohen A; Martin DW
Cell; 1976 Oct; 9(2):205-11. PubMed ID: 184961
[TBL] [Abstract][Full Text] [Related]
14. Combined familial adenosine deaminase and purine nucleoside phosphorylase deficiencies.
Shanon A; Levin S; Holtzman F; Brock-Sinai F; Abu-Said A
Arch Dis Child; 1988 Aug; 63(8):931-4. PubMed ID: 3137899
[TBL] [Abstract][Full Text] [Related]
15. Purinogenic immunodeficiency diseases: clinical features and molecular mechanisms.
Mitchell BS; Kelley WN
Ann Intern Med; 1980 Jun; 92(6):826-31. PubMed ID: 6247948
[TBL] [Abstract][Full Text] [Related]
16. Selective toxicity of purine nucleosides to human leukaemic cells.
Piga A; Ganeshaguru K; Green ES; Sheridan B; Hoffbrand AV
Adv Exp Med Biol; 1989; 253B():291-8. PubMed ID: 2514591
[TBL] [Abstract][Full Text] [Related]
17. [Immune insufficiency in enzyme defects of purine metabolism].
Müller G
Z Gesamte Inn Med; 1983 Feb; 38(3):83-9. PubMed ID: 6303005
[TBL] [Abstract][Full Text] [Related]
18. Adenosine deaminase and purine nucleoside phosphorylase activity in spleen cells of aged mice.
Scholar EM; Rashidian M; Heidrick ML
Mech Ageing Dev; 1980 Apr; 12(4):323-9. PubMed ID: 6771472
[TBL] [Abstract][Full Text] [Related]
19. Enzymes of the purine interconversion system in chronic lymphatic leukemia: decreased purine nucleoside phosphorylase and adenosine deaminase activity.
Ludwig H; Kuzmits R; Pietschmann H; Müller MM
Blut; 1979 Nov; 39(5):309-15. PubMed ID: 116697
[TBL] [Abstract][Full Text] [Related]
20. The correlation of adenosine deaminase and purine nucleoside phosphorylase activities in human lymphocytes subpopulations and in various lymphoid malignancies.
Demeocq F; Viallard JL; Boumsell L; Richard Y; Chassagne J; Plagne R; Lemerle J; Bernard A
Leuk Res; 1982; 6(2):211-20. PubMed ID: 6821120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
